Elafibranor Impurity 13

Elafibranor Impurity 13, chemically named (E)-3-(4-isopropoxy-3,5-dimethylphenyl)-1-(4-(methylthio)phenyl)prop-2-en-1-one (CAS No: NA), has a molecular formula of C₂₁H₂₄O₂S and a molecular weight of 340.5 g/mol. This high-purity pharmaceutical impurity standard is extensively used for API impurity analysis, drug substance characterization, and pharmaceutical quality control. It is critical for the detection and quantification of synthetic impurities, related compounds, and degradation products formed during active pharmaceutical ingredient manufacturing. Elafibranor Impurity 13 is commonly applied in analytical method development, HPLC impurity profiling, LC-MS/MS validation, and stability-indicating studies, ensuring precise and reliable results.

Manasa Life Sciences is a best manufacturer and global supplier of Elafibranor Impurity 13 and other certified pharmaceutical reference standards. We provide high-purity impurity materials with comprehensive analytical documentation, including COA, chromatographic purity reports, and structural characterization data. Headquartered in Hyderabad, India, we cater to global pharmaceutical markets, including Asia, Europe, Africa, the GCC, and the UAE, offering secure packaging, complete batch traceability, and strict adherence to USP and ICH guidelines. Leveraging our expertise in impurity isolation, structural analysis, and analytical method validation, we enable pharmaceutical manufacturers to achieve accurate impurity quantification, ensure regulatory compliance, and maintain the highest standards of drug quality and patient safety.